Julius Clinical invites you to their event

NASH webinar series - Insulin Resistance in NAFLD

November 29, 2022 17:00 (CET)
About 30 minutes

About this event

NASH Webinar Series

Webinar 6 - Insulin Resistance in NAFLD

Topics that will be discussed:

  1. Epidemiological links between NAFLD, insulin resistance and T2DM
  2. Insulin resistance as root cause of NAFLD: mechanistic insights
  3. Pharmacological development
  4. Development of multidisciplinary care

Speaker: Dr. Onno Holleboom, MD, PhD

Host: Prof. Manuel Castro Cabezas

Co-host: Prof. Christophe Moreno

Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers

----------------------------------------------------------------------------------------

NASH Webinar Series

This webinar is the third webinar of the NASH webinar series, each focusing on recent developments or publications on nonalcoholic steatohepatitis (NASH). The topics and publications are selected by KOLs of NASH Clinical based on relevant ground-breaking NASH research in a high-impact journal. During these webinars we offer you the opportunity to interact with original authors and experts in the NASH field.

Hosted by

  • Guest speaker
    EL G
    Elizabeth Liano

  • Guest speaker
    MH G
    Michelle Heuvelmans Marketing manager @ Julius Clinical

  • Guest speaker
    MC G
    Martin Czakon

  • Guest speaker
    CM G
    Christophe Moreno

  • Guest speaker
    MC G
    Manuel Castro Cabezas

  • Guest speaker
    OH G
    Onno Holleboom

Julius Clinical

The Academic CRO

Julius Clinical is the Academic Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.

View all events
Host webinars on Host webinars on Livestorm
Virtual Meetings ∙ Webinars ∙ Virtual Events ∙ On-Demand Webinars ∙ Automated Webinars ∙ Product Demos ∙ Company communication ∙ Customer training ∙ Live Q&As ∙ Employee onboarding ∙ Live events